プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
przewidywany termin rozpoczęcia badania – luty 2006.
to submit the final study report from the clinical study (ror104836), “ a randomised, double-blind, placebo- controlled, parallel group study to evaluate the efficacy and safety of ropinirole for 26 weeks and to further evaluate the incidence of augmentation and rebound for a further 40 weeks open label extension treatment period in subjects suffering from moderate to severe restless legs syndrome .” the study is expected to commence in feb 06.